Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


26.08.2019

1 Ann Surg
1 Br J Dermatol
2 Cancer Res
1 Clin Cancer Res
2 Int J Cancer
1 J Am Acad Dermatol
4 J Invest Dermatol
3 J Surg Oncol
4 Melanoma Res
1 Oncogene
1 Oncol Rep
1 Ophthalmology
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. LEICK KM, Rodriguez AB, Melssen MM, Benamar M, et al
    The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and Angiogenesis.
    Ann Surg. 2019 Aug 16. doi: 10.1097/SLA.0000000000003522.
    PubMed     Text format     Abstract available


    Br J Dermatol

  2. GOLDINGER SM, Valeska Matter A, Urner-Bloch U, Narainsing J, et al
    Binimetinib in heavily pretreated NRAS-mutant Melanoma Patients with Brain Metastases.
    Br J Dermatol. 2019 Aug 22. doi: 10.1111/bjd.18449.
    PubMed     Text format     Abstract available


    Cancer Res

  3. FEDDERSEN CR, Schillo JL, Varzavand A, Vaughn HR, et al
    Src-dependent DBL family members drive resistance to vemurafenib in human melanoma.
    Cancer Res. 2019 Aug 15. pii: 0008-5472.CAN-19-0244.
    PubMed     Text format     Abstract available

  4. LISCHER C, Eberhardt M, Jaitly T, Schinzel C, et al
    Curatopes Melanoma: a database of predicted T cell epitopes from overly expressed proteins in metastatic cutaneous melanoma.
    Cancer Res. 2019 Aug 15. pii: 0008-5472.CAN-19-0296.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. VASHISHT GOPAL YN, Gammon ST, Prasad R, Knighton B, et al
    A novel mitochondrial inhibitor blocks MAPK pathway and overcomes MAPK inhibitor-resistance in melanoma.
    Clin Cancer Res. 2019 Aug 22. pii: 1078-0432.CCR-19-0836.
    PubMed     Text format     Abstract available


    Int J Cancer

  6. VERVER D, van der Veldt A, van Akkooi A, Verhoef C, et al
    Reply to: The real-world outcome of metastatic melanoma: unknown primary versus known cutaneous.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32630.
    PubMed     Text format    

  7. ELLEBAEK E, Bastholt L, Schmidt H, Svane IM, et al
    The real-world outcome of metastatic melanoma: unknown primary versus known cutaneous.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32631.
    PubMed     Text format    


    J Am Acad Dermatol

  8. MANRIQUE-SILVA E, Reyes-Garcia D, Folgado B, Martin-Gorgojo A, et al
    The proportion of nevus-associated invasive melanoma differs with Breslow thickness: A cross-sectional study of 1087 cutaneous melanomas.
    J Am Acad Dermatol. 2019;81:852-854.
    PubMed     Text format    


    J Invest Dermatol

  9. HARDIE CM, Elliott F, Chan M, Rogers Z, et al
    Environmental exposures such as smoking and low vitamin D are predictive of poor outcome in cutaneous melanoma rather than other deprivation measures.
    J Invest Dermatol. 2019 Aug 16. pii: S0022-202X(19)32703.
    PubMed     Text format     Abstract available

  10. SHAUGHNESSY M, Njauw CN, Artomov M, Tsao H, et al
    Classifying melanoma by TERT promoter mutational status.
    J Invest Dermatol. 2019 Aug 16. pii: S0022-202X(19)32704.
    PubMed     Text format     Abstract available

  11. HANOUNA G, Tang E, Perez J, Vandermeersch S, et al
    Preventing Calpain Externalization by Reducing ABCA1 Activity with Probenecid Limits Melanoma Angiogenesis and Development.
    J Invest Dermatol. 2019 Aug 16. pii: S0022-202X(19)32702.
    PubMed     Text format     Abstract available

  12. DUFFY DL, Jagirdar K, Lee KJ, McWhirter SR, et al
    Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls.
    J Invest Dermatol. 2019 Aug 14. pii: S0022-202X(19)32695.
    PubMed     Text format    


    J Surg Oncol

  13. ZHOU AY, Wang DY, McKee S, Ye F, et al
    Correlates of response and outcomes with talimogene laherperpvec.
    J Surg Oncol. 2019;120:558-564.
    PubMed     Text format     Abstract available

  14. STAHLIE EHA, Blankenstein SA, van Houdt WJ, Wouters MWJM, et al
    A systematic review and meta-analysis of locoregional treatments for in-transit melanoma.
    J Surg Oncol. 2019 Aug 22. doi: 10.1002/jso.25685.
    PubMed     Text format    

  15. READ T, Lonne M, Sparks DS, David M, et al
    Response to Stahlie et al regarding "A systematic review and meta-analysis of locoregional treatments for in-transit melanoma".
    J Surg Oncol. 2019 Aug 22. doi: 10.1002/jso.25686.
    PubMed     Text format    


    Melanoma Res

  16. PRIOR L, Toomey S, Greally M, Keane F, et al
    Genomic profiling of a dedifferentiated mucosal melanoma following exposure to immunotherapy.
    Melanoma Res. 2019 Aug 14. doi: 10.1097/CMR.0000000000000636.
    PubMed     Text format     Abstract available

  17. SORICH MJ, Rowland A, Hopkins AM
    Validation of dabrafenib-trametinib prognostic groups in patients treated with vemurafenib and cobimetinib for advanced BRAF-mutated melanoma.
    Melanoma Res. 2019 Aug 14. doi: 10.1097/CMR.0000000000000634.
    PubMed     Text format     Abstract available

  18. POSTOW MA, Chasalow SD, Kuk D, Panageas KS, et al
    Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab.
    Melanoma Res. 2019 Aug 14. doi: 10.1097/CMR.0000000000000633.
    PubMed     Text format     Abstract available

  19. HUSSAIN RN, Heimann H, Damato B
    Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study.
    Melanoma Res. 2019 Aug 14. doi: 10.1097/CMR.0000000000000635.
    PubMed     Text format    


    Oncogene

  20. HWANG BJ, Zhang Y, Brozowski JM, Liu Z, et al
    The dysfunction of BP180/collagen XVII in keratinocytes promotes melanoma progression.
    Oncogene. 2019 Aug 21. pii: 10.1038/s41388-019-0961.
    PubMed     Text format     Abstract available


    Oncol Rep

  21. MACZYNSKA J, Choromanska A, Kutkowska J, Kotulska M, et al
    Effect of electrochemotherapy with betulinic acid or cisplatin on regulation of heat shock proteins in metastatic human carcinoma cells in vitro.
    Oncol Rep. 2019;41:3444-3454.
    PubMed     Text format     Abstract available


    Ophthalmology

  22. MICIELI JA, Newman NJ, Biousse V
    Retinal Imaging of an Optic Tract Lesion: OCT Angiography of Structural and Functional Defects.
    Ophthalmology. 2018;125:756.
    PubMed     Text format    


    PLoS One

  23. BOCHEM J, Zelba H, Amaral T, Spreuer J, et al
    Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.
    PLoS One. 2019;14:e0221301.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  24. ABUHAMMAD S, Cullinane C, Martin C, Bacolas Z, et al
    Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2019 Aug 22. pii: 1901323116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: